Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
30,771,922
-
Share change
-
+1,137,972
-
Total reported value
-
$36,332,345
-
Put/Call ratio
-
7.7%
-
Price per share
-
$1.18
-
Number of holders
-
61
-
Value change
-
-$2,099,186
-
Number of buys
-
30
-
Number of sells
-
26
Institutional Holders of INFINITY PHARMACEUTICALS INC - COM (INFI) as of Q4 2018
As of 31 Dec 2018,
INFINITY PHARMACEUTICALS INC - COM (INFI) was held by
61 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,771,922 shares.
The largest 10 holders included
BVF INC/IL, Vanguard Group Inc, WELLINGTON MANAGEMENT GROUP LLP, PLATINUM INVESTMENT MANAGEMENT LTD, DIMENSIONAL FUND ADVISORS LP, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, BAKER BROS. ADVISORS LP, First Eagle Investment Management, LLC, and OXFORD ASSET MANAGEMENT LLP.
This page lists
61
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.